205 related articles for article (PubMed ID: 33976978)
1. Development and validation of an oxidative stress-associated prognostic risk model for melanoma.
Yang Y; Long X; Li K; Li G; Yu X; Wen P; Luo J; Tian X; Zhao J
PeerJ; 2021; 9():e11258. PubMed ID: 33976978
[TBL] [Abstract][Full Text] [Related]
2. Identification of hub prognosis-associated oxidative stress genes in skin cutaneous melanoma using integrated bioinformatic analysis.
Ren TY; Zhang YX; Hu W
Eur Rev Med Pharmacol Sci; 2021 Apr; 25(7):2927-2940. PubMed ID: 33877656
[TBL] [Abstract][Full Text] [Related]
3. Analysis on tumor immune microenvironment and construction of a prognosis model for immune-related skin cutaneous melanoma.
Wu M; Wang Z; Zhang J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):671-681. PubMed ID: 37539569
[TBL] [Abstract][Full Text] [Related]
4. The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature.
Zhou S; Sun Y; Chen T; Wang J; He J; Lyu J; Shen Y; Chen X; Yang R
Front Cell Dev Biol; 2021; 9():739594. PubMed ID: 34660598
[TBL] [Abstract][Full Text] [Related]
5. System analysis based on the pyroptosis-related genes identifes GSDMD as a novel therapy target for skin cutaneous melanoma.
Zhao S; Zhu Y; Liu H; He X; Xie J
J Transl Med; 2023 Nov; 21(1):801. PubMed ID: 37950289
[TBL] [Abstract][Full Text] [Related]
6. Novel oxidative stress-related prognostic biomarkers for melanoma associated with tumor metastasis.
Wu X; Zhao J
Medicine (Baltimore); 2021 Feb; 100(8):e24866. PubMed ID: 33663112
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of an immune gene set-based prognostic signature in cutaneous melanoma.
Tian Q; Gao H; Zhao W; Zhou Y; Yang J
Future Oncol; 2021 Nov; 17(31):4115-4129. PubMed ID: 34291650
[TBL] [Abstract][Full Text] [Related]
8. Predicting the clinical outcome of melanoma using an immune-related gene pairs signature.
Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li W; Li J; Xiao Y
PLoS One; 2020; 15(10):e0240331. PubMed ID: 33031392
[TBL] [Abstract][Full Text] [Related]
9. Low expression of endoplasmic reticulum stress-related gene SERP1 is associated with poor prognosis and immune infiltration in skin cutaneous melanoma.
Fan Y; Liang X; Yu D
Aging (Albany NY); 2021 Oct; 13(19):23036-23071. PubMed ID: 34613934
[TBL] [Abstract][Full Text] [Related]
10. A Novel Necroptosis-Related Gene Signature in Skin Cutaneous Melanoma Prognosis and Tumor Microenvironment.
Song B; Wu P; Liang Z; Wang J; Zheng Y; Wang Y; Chi H; Li Z; Song Y; Yin X; Yu Z; Song B
Front Genet; 2022; 13():917007. PubMed ID: 35899194
[No Abstract] [Full Text] [Related]
11. Characterization of coagulation-related gene signature to predict prognosis and tumor immune microenvironment in skin cutaneous melanoma.
Song B; Chi H; Peng G; Song Y; Cui Z; Zhu Y; Chen G; Wu J; Liu W; Dong C; Wang Y; Xu K; Yu Z; Song B
Front Oncol; 2022; 12():975255. PubMed ID: 36059641
[TBL] [Abstract][Full Text] [Related]
12. Construction and validation of a novel pyroptosis-related signature to predict prognosis in patients with cutaneous melanoma.
Niu Z; Xu Y; Li Y; Chen Y; Han Y
Math Biosci Eng; 2022 Jan; 19(1):688-706. PubMed ID: 34903008
[TBL] [Abstract][Full Text] [Related]
13. Analysis of immune subtypes based on immunogenomic profiling identifies prognostic signature for cutaneous melanoma.
Hu B; Wei Q; Zhou C; Ju M; Wang L; Chen L; Li Z; Wei M; He M; Zhao L
Int Immunopharmacol; 2020 Dec; 89(Pt A):107162. PubMed ID: 33168410
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of the prognosis and biological significance for IFIT family in skin cutaneous melanoma.
Jiang Y; Zhang C; Zhang J; Han D; Shi X
Int Immunopharmacol; 2021 Dec; 101(Pt A):108344. PubMed ID: 34763233
[TBL] [Abstract][Full Text] [Related]
15. Identification of anoikis-related subtypes and development of risk stratification system in skin cutaneous melanoma.
Tian J; Cao ZJ; Zhang Y; Zhou JK; Yang L
Heliyon; 2023 May; 9(5):e16153. PubMed ID: 37215879
[TBL] [Abstract][Full Text] [Related]
16. Establishment and validation of an autophagy-related prognostic signature for survival predicting in cutaneous melanoma.
Fei H; Chen X
Am J Cancer Res; 2021; 11(12):5979-5991. PubMed ID: 35018237
[TBL] [Abstract][Full Text] [Related]
17. New Prognostic Biomarkers and Drug Targets for Skin Cutaneous Melanoma
Zhou S; Han Y; Li J; Pi X; Lyu J; Xiang S; Zhou X; Chen X; Wang Z; Yang R
Front Oncol; 2021; 11():745384. PubMed ID: 34722301
[TBL] [Abstract][Full Text] [Related]
18. Ferroptosis-Related Gene Signature Predicts the Prognosis of Skin Cutaneous Melanoma and Response to Immunotherapy.
Xu Z; Xie Y; Mao Y; Huang J; Mei X; Song J; Sun Y; Yao Z; Shi W
Front Genet; 2021; 12():758981. PubMed ID: 34804126
[TBL] [Abstract][Full Text] [Related]
19. Construction of Prognostic Risk Model of Patients with Skin Cutaneous Melanoma Based on TCGA-SKCM Methylation Cohort.
Yu X; Cong P; Wei W; Zhou Y; Bao Z; Hou H
Comput Math Methods Med; 2022; 2022():4261329. PubMed ID: 36060650
[TBL] [Abstract][Full Text] [Related]
20. Identification of immune-related biomarkers associated with tumorigenesis and prognosis in cutaneous melanoma patients.
Huang B; Han W; Sheng ZF; Shen GL
Cancer Cell Int; 2020; 20():195. PubMed ID: 32508531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
